Earnings Feed
Start Free
Sage Therapeutics, Inc.·4

Jan 11, 4:02 PM ET

IGUCHI KIMI 4

4 · Sage Therapeutics, Inc. · Filed Jan 11, 2023

Insider Transaction Report

Form 4
Period: 2023-01-09
Sage Therapeutics, Inc.SAGE
IGUCHI KIMI
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-09$1.36/sh+1,600$2,176→ 59,624 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-09−1,600→ 5,642 total
    Exercise: $1.36Exp: 2024-01-22→ Common Stock (1,600 underlying)
Footnotes (1)
  • [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.

Documents

2 files